- Corporate Officers - V
- Versant Vantage I Gp-gp, Llc
Insider Trading History of Versant Vantage I Gp-gp, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Versant Vantage I Gp-gp, Llc since 2019.
This trader's CIK number is 1777653.
At the time of last reporting, Versant Vantage I Gp-gp, Llc was the Officer of Lava Therapeutics Nv. (stock ticker symbol LVTX).
Also see all insider trading activities at Lava Therapeutics Nv.
Note that in the past
Versant Vantage I GP-GP, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Repare Therapeutics Inc. (RPTX) by Versant Vantage I Gp-gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | RPTX | 0 | $0 | 750,000 | $9,189,000 | 0 | $0 |
| 2020 | RPTX | 250,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Monte Rosa Therapeutics, Inc. (GLUE) by Versant Vantage I Gp-gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | GLUE | 0 | $0 | 1,857,674 | $12,297,510 | 0 | $0 |
| 2021 | GLUE | 157,895 | $3,000,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lava Therapeutics Nv (LVTX) by Versant Vantage I Gp-gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LVTX | 0 | $0 | 4,587,837 | $6,569,828 | 0 | $0 |
Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Versant Vantage I Gp-gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | APRE | 333,333 | $4,999,995 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Versant Vantage I Gp-gp, Llc:
1. Repare Therapeutics Inc. (RPTX)
2. Monte Rosa Therapeutics, Inc. (GLUE)
3. Lava Therapeutics Nv (LVTX)
4. Aprea Therapeutics, Inc. (APRE)
Table 1. Insider trading of Repare Therapeutics Inc. (RPTX) by Versant Vantage I Gp-gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-03 | RPTX | Sale | 750,000 | 12.25 | 9,189,000 |
| 2020-06-23 | RPTX | Buy | 250,000 | 20.00 | 5,000,000 |
Table 2. Insider trading of Monte Rosa Therapeutics, Inc. (GLUE) by Versant Vantage I Gp-gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-10-28 | GLUE | Sale | 89,990 | 9.66 | 869,213 |
| 2024-10-29 | GLUE | Sale | 67,905 | 9.25 | 627,849 |
| 2024-09-20 | GLUE | Sale | 1,132,566 | 6.53 | 7,395,655 |
| 2024-09-13 | GLUE | Sale | 9,269 | 6.16 | 57,097 |
| 2024-09-11 | GLUE | Sale | 541,897 | 6.00 | 3,251,382 |
| 2024-09-12 | GLUE | Sale | 16,047 | 6.00 | 96,314 |
| 2021-06-28 | GLUE | Buy | 157,895 | 19.00 | 3,000,005 |
Table 3. Insider trading of Lava Therapeutics Nv (LVTX) by Versant Vantage I Gp-gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-19 | LVTX | Sale | 2,903,403 | 1.40 | 4,067,667 |
| 2025-09-16 | LVTX | Sale | 500,000 | 1.53 | 766,500 |
| 2025-09-17 | LVTX | Sale | 589,532 | 1.49 | 877,813 |
| 2025-09-18 | LVTX | Sale | 594,902 | 1.44 | 857,848 |
Table 4. Insider trading of Aprea Therapeutics, Inc. (APRE) by Versant Vantage I Gp-gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-10-07 | APRE | Buy | 333,333 | 15.00 | 4,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Versant Vantage I Gp-gp, Llc
(Officer of Lava Therapeutics Nv at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.